Johnstone Tcheou

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Protein Protein

Magnetic Resonance

Top Venues

Science translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata, Charles Gleason, Komal Srivastava, Vladimir Vigdorovich, Nicholas Dambrauskas, Sneh Lata Gupta, Irene González Domínguez, Jose Luis Martinez, Stefan A Slamanig, D Noah Sather, Rama Raghunandan, Ponthip Wirachwong, Sant Muangnoicharoen, Punnee Pitisuttithum, Jens Wrammert, Mehul S Suthar, Weina Sun, Peter Palese, Adolfo García-Sastre, Viviana Simon, Florian Krammer
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Science translational medicine 15 (683) (2023)
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata, Charles Gleason, Komal Srivastava, Vladimir Vigdorovich, Nicholas Dambrauskas, Sneh Lata Gupta, Irene González Domínguez, Jose Luis Martinez, Stefan A Slamanig, D Noah Sather, Rama Raghunandan, Ponthip Wirachwong, Sant Muangnoicharoen, Punnee Pitisuttithum, Jens Wrammert, Mehul S Suthar, Weina Sun, Peter Palese, Adolfo García-Sastre, Viviana Simon, Florian Krammer
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Science translational medicine 15 (683) (2023)
Juan Manuel Carreño, Ariel Raskin, Gagandeep Singh, Johnstone Tcheou, Hisaaki Kawabata, Charles Gleason, Komal Srivastava, Vladimir Vigdorovich, Nicholas Dambrauskas, Sneh Lata Gupta, Irene González Domínguez, Jose Luis Martinez, Stefan A Slamanig, D Noah Sather, Rama Raghunandan, Ponthip Wirachwong, Sant Muangnoicharoen, Punnee Pitisuttithum, Jens Wrammert, Mehul S Suthar, Weina Sun, Peter Palese, Adolfo García-Sastre, Viviana Simon, Florian Krammer
An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination. Science translational medicine 15 (683) (2023)